
Nilotinib and bosutinib modulate pre-plaque alterations of blood immune markers and neuro-inflammation in Alzheimer's disease models
Keywords: 3،3'-diaminobenzidine; Abl; Abelson; AD; Alzheimer's disease; DAB; 3,3â²-diaminobenzidine; DAPI; 4â²,6-diamidino-2-phenylindole; DMSO; dimethyl sulfoxide; ELISA; enzyme-linked immunosorbent assay; GFAP; Glial Fibrillary Acid Protein; IBA; ionized calcium-binding adapter; IF